Filters: author is Schaddelee [Clear All Filters]
- 2005
Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain,
Eur J Pharmacol, vol. 514, no. 2-3, pp. 131-40. DOI
Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents,
Eur J Pharm Sci, vol. 24, no. 1, pp. 59-66. DOI
- 2004
Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5'deoxy-N6-cylopentyladenosine in the mononeuropathic rat,
Eur J Pharmacol, vol. 504, no. 1-2, pp. 7-15. DOI
Population pharmacokinetic modeling of blood-brain barrier transport of synthetic adenosine A1 receptor agonists,
J Pharmacol Exp Ther, vol. 311, no. 3, pp. 1138-46. DOI
- 2003
Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: structure transport relationships,
Eur J Pharm Sci, vol. 20, no. 3, pp. 347-56. DOI
Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives,
Eur J Pharm Sci, vol. 19, no. 1, pp. 13-22. DOI


